The latest closing stock price for Citius Oncology as of April 11, 2025 is 0.67.
An investor who bought $1,000 worth of Citius Oncology stock at the IPO in 2024 would have $-983 today, roughly -1 times their original investment - a -98.34% compound annual growth rate over 1 years.
The all-time high Citius Oncology stock closing price was 40.50 on August 12, 2024.
The Citius Oncology 52-week high stock price is 40.50, which is 5944.8% above the current share price.
The Citius Oncology 52-week low stock price is 0.55, which is 17.9% below the current share price.
The average Citius Oncology stock price for the last 52 weeks is 1.46.
An investor who bought $1,000 worth of Citius Oncology stock at the IPO in 2024 would have $-983 today, roughly -1 times their original investment - a -98.34% compound annual growth rate over 1 years.
The all-time high Citius Oncology stock closing price was 40.50 on August 12, 2024.
The Citius Oncology 52-week high stock price is 40.50, which is 5944.8% above the current share price.
The Citius Oncology 52-week low stock price is 0.55, which is 17.9% below the current share price.
The average Citius Oncology stock price for the last 52 weeks is 1.46.